NASDAQ:FULC
Fulcrum Therapeutics, Inc. Stock News
$7.75
+0.1000 (+1.31%)
At Close: May 03, 2024
Fulcrum Therapeutics Appoints Katina Dorton to its Board of Directors
12:00pm, Monday, 06'th Jan 2020
Fulcrum Therapeutics, Inc. (FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the appointment of Kat
Hedge Funds Have Never Been This Bullish On Fulcrum Therapeutics, Inc. (FULC)
06:47pm, Monday, 16'th Dec 2019
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good additi
Xconomy: Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts
01:01pm, Thursday, 18'th Jul 2019
Initial public offerings took a brief summer break the week of Independence Day, but healthcare IPO activity resumed this week as three more companies
